Poster discussion hub abstracts from biparietal diameter and abdominal circumference using the eSnurra algorithm. Mean fetal weight gain/day was calculated as the difference between birthweight and estimated fetal weight in the second trimester, and thereafter related to the remaining days in pregnancy from the ultrasound examination to delivery. Results: We observed a significant association between mean flow calculated from PixelFlux and weight gain/day (r =0.33; p =0.02) as presented in the Figure. The correlations remained significant after adjusting for maternal age, BMI, parity and systolic blood pressure (p =0.01 and p =0.02, respectively). Conclusions: We found a significant association between total blood flow based on PixelFlux and fetal weight-gain/day. The PixelFlux method might be a promising tool in predicting birthweight.
Objectives:
We assessed the ultrasound pattern of visceral abdominal fat (VAT) in adequate weight, overweight and obese pregnant patients and estimate misclassification of metabolic risk. Methods: We evaluated 61 outpatients in the first 20 weeks of pregnancy. Pre-pregnancy weight was obtained through first medical evaluation and height was measured in the clinic. VAT was measured using ultrasound according the Armellini technique. We used two cut off measures to identify abnormal VAT. A normal VAT lower of 36.6 mm was based on means of 3 previous studies in pregnant women (normal cut-off). VAT higher than 47.3 mm was used as high risk for diabetes, as previously reported (diabetes cut-off). Patients were divided in adequate weight or pre-pregnant maternal (BMI) ∠25 kg/m2, overweight or BMI 25-29.9 kg/m 2 and obese BMI 30 kg/m 2 .
Results:
We found a strong correlation between BMI and VAT (r=0.58, p∠0.001). Mean VAT was 35.3 ± 11.4mm in adequate weight group, 40.0 ± 8.6mm in overweight group and 50.1± 20.4mm among obese patients. Among adequate weight patients we found that 42.3% had VAT higher than normal cut-off and 11.5% higher than diabetes cut-off. In the overweight group, 71.4% had VAT higher than normal cut-off and 21.4% had higher than diabetes cut-off. In the obese group 81.0% had VAT above normal cut-off and 42.9% had VAT higher than diabetes cut-off. Objectives: Vasa previa (VP) has a reported fetal mortality of 60% if not recognised before attempt at vaginal delivery. Prenatal detection by ultrasound is possible in nearly all cases, but can be notoriously difficult unless there is a high index of suspicion. We report our experience in detection of VP using a structured protocol as part of the routine fetal anomaly scan at 20-22 weeks. Methods: Patients attending anomaly screening at a single centre over a 5 year period (2012-2016) underwent assessment for VP using a structured protocol as a part of a routine fetal anatomy scan. Suspected cases of VP were then re-scanned by a specialist sonographer and subsequently followed up. The diagnosis of VP was assigned by documentation of fetal vessels beneath the membranes, within 20 mm of the internal cervical os. Results: 24690 anatomy scans were performed during the study period and 56 of these were identified as potential VP at the 20 -22 week anomaly scan. Of these, 20 were confirmed by the ultrasound specialist at 28 weeks or later. In five patients the only risk factor was a velamentous insertion. All 20 patients had planned Caesarean delivery but one patient bled at 35 weeks before planned delivery and this fetus died. Another patient experienced bleeding and an emergency Caesarean delivery at 31 weeks 3 days, and this baby lived. The remaining 18 had Caesarean delivery as planned. Placental histology was available in 11 cases. No case of VP was unexpectedly found at delivery during the study period (100% detection).
Conclusions:
The incidence of vasa previa in this unselected population is 1:1234. Use of a specific protocol as part of routine screening, permits high detection rate (100%), resulting in a low (5%) fetal mortality. We suggest that assessment for VP should be incorporated into routine fetal anatomy screening at 20-22 weeks using a structured protocol similar to one presented here.
